» Articles » PMID: 31737204

LMO4 Promotes the Invasion and Proliferation of Gastric Cancer by Activating PI3K-Akt-mTOR Signaling

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2019 Nov 19
PMID 31737204
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

This study assessed the biological functions of LIM-domain-only 4 (LMO4) in gastric cancer (GC) and investigated the underlying molecular mechanisms. It was found that the expression of LMO4 was significantly upregulated in GC tissues and closely associated with clinicopathological factors, overall survival and disease-free survival of patients. After knockdown of LMO4 in MGC-803 and SGC-7901 cells, invasion and proliferation were obviously suppressed. Furthermore, LMO4 knockdown suppressed the phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt and mammalian target of rapamycin (mTOR). Miltefosine, the inhibitor of PI3K/Akt, and dactolisib, the inhibitor of mTOR, abrogated recombinant LMO4-induced GC cell invasion and proliferation. These results suggest that LMO4 promotes GC cell invasion and proliferation mainly through PI3K-Akt-mTOR signaling. LMO4 may serve as a potential therapeutic target for GC in the future.

Citing Articles

Nimodipine Used with Vincristine: Protects Schwann Cells and Neuronal Cells from Vincristine-Induced Cell Death but Increases Tumor Cell Susceptibility.

Scheer M, Polak M, Fritzsche S, Strauss C, Scheller C, Leisz S Int J Mol Sci. 2024; 25(19).

PMID: 39408743 PMC: 11476576. DOI: 10.3390/ijms251910389.


Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.

Morgos D, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S Int J Mol Sci. 2024; 25(3).

PMID: 38339127 PMC: 10856016. DOI: 10.3390/ijms25031848.


Recent findings on miR‑370 expression, regulation and functions in cancer (Review).

Ye L, Wang J, Yi K, Wang F, Wang J, Wu H Oncol Rep. 2023; 49(4).

PMID: 36866765 PMC: 10018457. DOI: 10.3892/or.2023.8516.


HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms.

Han B, Liu Z, Hu X, Ling H Cell Death Dis. 2022; 13(11):940.

PMID: 36347834 PMC: 9643420. DOI: 10.1038/s41419-022-05376-6.


Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying miR-655-3p inhibit the development of esophageal cancer by regulating the expression of HIF-1α via a LMO4/HDAC2-dependent mechanism.

Chen M, Xia Z, Deng J Cell Biol Toxicol. 2022; 39(4):1319-1339.

PMID: 36222945 DOI: 10.1007/s10565-022-09759-5.


References
1.
Zhou J, Shen J, Seifer B, Jiang S, Wang J, Xiong H . Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer. Oncotarget. 2016; 8(18):30477-30494. PMC: 5444758. DOI: 10.18632/oncotarget.12955. View

2.
Montanez-Wiscovich M, Seachrist D, Landis M, Visvader J, Andersen B, Keri R . LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene. 2009; 28(41):3608-18. PMC: 2762490. DOI: 10.1038/onc.2009.221. View

3.
Sun X, Mu R, Zhou Y, Dai X, Qiao Y, Zhang S . [1990-1992 mortality of stomach cancer in China]. Zhonghua Zhong Liu Za Zhi. 2002; 24(1):4-8. View

4.
Becker K, Keller G, Hoefler H . The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol. 2001; 9(1):5-11. DOI: 10.1016/s0960-7404(00)00016-5. View

5.
Simonik E, Cai Y, Kimmelshue K, Brantley-Sieders D, Loomans H, Andl C . LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer). PLoS One. 2016; 11(10):e0164804. PMC: 5079595. DOI: 10.1371/journal.pone.0164804. View